YOB-1604

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameYOB-1604
Drug Alias NameYOB-1604
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesYungjin Pharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYungjin Pharmaceutical
Active IndicationsN/A
Inactive IndicationsProstatic Hyperplasia

Other Information

ATC CodeN/A
Related LinksN/A